Introduction
The debate regarding surgery on asymptomatic or mildly symptomatic patients with aortic valve disease (AVD) is longstanding.
1,2 Brock recommended invasive investigation and intervention before the advent of heart failure. 3 The median time to death with stenosis (AS) is 4.5 years after chest pain, 2.6 years after syncope and 1 year after heart failure, with a 5-year survival of less than 20%. 4 In untreated aortic regurgitation, long-term survival is curtailed, especially in patients with reduced functional class and elevated end-systolic dimensions. 5 Surgery improves outcomes even in the setting of left ventricular dysfunction. 6 The increasing incidence of AVD in the elderly population renders this condition a significant public-health problem. It is against this control group, with up to 12% incidence in the over 75's, that the impact of surgery should be evaluated. 7 When patients die within 30 days of surgery, death is attributed to the procedure. However the cause of late death is often undetermined because of inaccurate information. The effect of surgery on long-term survival may be evaluated in a relative survival model. 8 This long-term study compares survival after aortic valve replacement (AVR) with local age-and gendermatched controls, providing an estimate of predicted postoperative life expectancy. Patients understand that operative risk is offset by a predicted significant survival enhancement with AVR. They also wish to know whether surgery can restore normal life expectancy.
Long-term survival is determined by post-operative survival, the lasting effects of surgery, and continuing medical therapy. Survival prediction is meaningful when taken in context with local relative survival analysis, incorporating data from national life expectancy tables and local post-operative outcome data. 9 The inclusion of variables other than age and gender may further enhance risk-benefit assessment. 10 Such analysis aids decision making regarding surgery, particularly in elderly patients, when individual risk scores are of limited value. 9 
Methods

Study design
The Ethical Committee of the University of Malta granted approval for this study. 585 consecutive patients undergoing AVR, with or without concomitant coronary revascularization, between January 1995 and December 2014, in a single-surgeon practice, were entered into the study. Patients requiring combined procedures on the mitral valve or the ascending aorta were excluded.
Patients and protocols
All procedures were performed on normothermic cardiopulmonary bypass with a membrane oxygenator. 
Data collection
Data was collected by the surgeon and entered into an electronic database. Patient risk assessment was calculated at the preoperative visit, operative parameters were entered at the termination of surgery, and in-hospital clinical course was completed at the patient's discharge. Parsonnet risk stratification was used from the outset of the study whilst additive and logistic EuroSCORE were also used from 2000 and 2006 respectively. The logistic EuroSCORE for patients entered between 2000 and 2006 was calculated retrospectively. Data collected prospectively was combined with patient data pertaining to survival or date of death derived from the Patient Administration System while general population survival data was derived from the National Statistics Office database.
Endpoints
Absolute survival after AVR is presented as Kaplan-Meier survival curves for four subgroups of the surgical population. Hazard ratios were calculated for certain demographic, operative and post-operative clinical parameters. Relative survival curves relate the post-operative absolute survival curves with those of an age-and gender-matched population for the matched follow-up year, derived from the National Statistics Office database.
Risk variables
Variables selected for evaluation were categorized according to patient characteristics, the procedure, and the in-hospital post-operative course. 
Relative survival
Relative survival is the ratio of the observed survival to the expected survival patients would experience had they been exposed only to the survival probabilities of the general population (background mortality 
Statistical Methods
Means and standard deviations were used to measure central tendency and dispersion for continuous variables and frequency tables and crosstabs were used to describe categorical variables. Statistical inference was carried out using the One-Way ANOVA and Chi square tests. The One-Way ANOVA test compares means of patient-related, procedural and post-operative continuous variables between independent age groups (15-59, 60-67, 68-73 and >74 years). The Chi squared test assesses the association between patient-related, procedural and post-operative categorical variables and age groups. Survival probabilities for the study cohort (total population and age specific groups) and the age-and gender-matched population were computed using the Kaplan-Meier estimate. Cox regression analysis was used to relate survival times (follow-up duration) to a number of patient-related, procedural and post-operative predictors, where the patients who were still alive at the end of the investigation period were right censored. The hazard ratios and their 95% confidence intervals were computed for each of these risk/protective variables.
Results
Study cohort
585 patients were divided into four age ranges of comparable size (groups A-D), as determined by the closest whole year integer (table 1) . 224 (38.3%) were female, and incidence increased with age. All in-hospital deaths (2.1%) were classified as peri-operative deaths, even if they occurred after 30 days from surgery. Survivors were defined as patients who were discharged from hospital and survived surgery beyond 30 days. Amongst survivors the mean and maximum follow-up for each group is shown in table 1. The mean follow-up was shorter with increasing age, reflecting a trend for more surgery in the elderly in recent years. The annualized percentage death rate (ADR%) was derived by dividing the number of deaths other than peri-operative deaths (expressed as a percentage of the group) by the mean follow-up in years. 93% (322/348) patients under 70 received a mechanical valve, whereas 95% (226/237) patients over 70 received a tissue valve. Concomitant revascularization was highest in group C whilst the requirement for urgent surgery was highest in group D (table 2). The valve lesion was classified as stenosis, mixed (stenosis and regurgitation) or pure regurgitation. The incidence of combined stenosis and mixed valve disease increased with age, whereas pure regurgitation was rare (<4%) in group D. Risk stratification score increased with age, with a significant increment in Parsonnet in the over 70's and a similar increment in the EuroSCORE in the over 60's, in-keeping with the weighting design of these systems.
Absolute survival
The mean follow-up in survivors was 8.2 years (median 7.6 years). The follow-up period was 20 years and during this time 407 patients were censored and 178 patients died. There were 12 peri-operative deaths (2.1%), 4 deaths in the valve replacement only group (1.0%, n=386) and 8 in the valve replacement + CABG group (4.0%, n=199). The predicted mortality for the whole group was 5.2% by additive EuroSCORE and 4.9% by logistic EuroSCORE. Another 11 patients (1.9%) died within the first year after surgery and a further 154 (26.3%) died beyond the first year. 408 patients (69.7%) were alive at the end of the 20-year follow-up period. The absolute survival Kaplan-Meier curves for the entire study group as well as for the age-defined sub-groups are presented in figure 1.
The risk indicators for the sub-groups A to D are presented in table 3. A hazard ratio (HR) above 1.0 ascribes an increased propensity for an event in the presence of certain variables, categorized as patient variables, procedure variables and postoperative variables, while a hazard ratio below 1.0 ascribes a protective factor (tables 4 and 5). 
Patient variables
Relative survival
Patients included in this analysis (n=524) underwent surgery up to 2013 to allow for a minimum follow-up of a year. Relative survival curves were plotted by age groups and follow-up time was truncated at the point where less than 50 patients remained at risk. Figure 2 shows the survival curve with 95% confidence intervals for the total population. The one-year relative survival probability (98.2%, 95% CI 96.0-99.6) was slightly lower in the first year than the survival expected in age-and gender-matched counter parts. However the 5-year (99.3%, 95% CI 95.5-102.4) and 10 year survival probability (98.1%, 95% CI 91.7-104.5) show similar survival. Relative survival hazard was significantly lower in groups B, C and D when compared with group A (figure 3). Analysis by age groups was performed for the four age groups and also for two amalgamated age groups (15-67 and 68+) to allow for more robust analysis (figure 2). Survival in the15-67 age group remains lower than the age-and gender-matched general population over the 10 years of follow up (upper CI does not surpass 1). For those aged 68+ no difference in survival was noted for age-and gender-matched counterparts except at the fourth year of follow up where patients showed a higher survival probability (106%, 95% CI 100.6-110.3). In spite of wider confidence intervals with increasing follow-up, the data suggests that survival in the 68+ group is better than that in the younger age group. 
Discussion Findings and Data interpretation
A higher risk stratification score predicted an increased propensity for reduced long-term survival. Although the additive and logistic EuroSCORE have superseded the older Parsonnet system, the latter remained the strongest indicator for long-term survival when subjected to multivariate analysis. Parsonnet score is a reliable predictor of intensive care stay and of complications including intra-aortic balloon pump use and renal replacement therapy, variables that strongly predicted long-term outcome in our study. 12 Despite its shortcomings in over-predicting operative mortality, Parsonnet remains a simple and useful predictor of long-term survival after AVR.
Despite the guarded prognosis associated with pure aortic regurgitation reported in previous studies, our results do not support this variable as a significant risk predictor of decreased long-term survival. 2, 13 Confounding factors in our study include a preserved EF of 65.1±15.8% (75% had an EF >55%) in spite of a significantly increased left ventricular end-systolic volume of 66.5±41.1ml as calculated at ventriculography, suggesting that surgery was performed expeditiously. The small numbers in the elderly subgroup may pose a further study limitation. The effect of prosthesis-patient mismatch (PPM) on long-term survival was evaluated by using the indexed Effective Orifice Area (EOA) for each size category and for the entire group. An 25) . Ninety-three cases of moderate PPM occurred in patients over 70 receiving a xenograft, in whom a presumed relatively curtailed activity would reduce the impact of trans-valvular flow on trans-valvular pressure gradient. Our incidence of mismatch is lower than that quoted in other series using the same criteria. 16, 17 For size 19 valves, mismatch impacted negatively on long-term survival, with mortality increasing by 12.7% when compared with the other sizes, suggesting that valve size was a more important predictor than valve type or model. Mismatch in larger sizes had no significant impact on long-term survival.
Peri-operative transfusion has been shown independently to double 5-year mortality after cardiac surgery. We demonstrated a similar trend after AVR. Blood was administered more frequently in older and smaller patients, variables associated with a decreased long-term survival in our study. 18, 19 New-onset atrial fibrillation or flutter increased with age and was a significant predictor of reduced long-term survival (HR 1.618). This is in keeping with a similar study by Filardo et al, citing an HR of 1.48. 20 The strongest post-operative indicator for a poor long-term outcome was renal dialysis (HR 8.737), also reported in a previous study, 10 followed by IABP usage (HR 4.567), which has been reported to affect both early and late mortality after AVR. 21 Other significant variables, reported in previous studies, were not analysed in our study due to a very low incidence. Thus Lassnigg et al reported an HR of 1.8 for resternotomy, which occurred in 9.36% of cases (173/1848 patients) whilst our incidence was significantly less at 2.05% (p<0.0001). Similarly our incidence of reoperation was 2.56%, compared with Lassnigg's 9.90%. 10 The newer alternative therapy of transcatheter aortic valve implantation (TAVI) may significantly impact the long-term survival of patients with aortic valve disease. 22 Although patients were increasingly treated by this method in Malta since 2010, these were not included in this study.
Clinical implications
This study demonstrates multiple variables that impacted absolute long-term survival. Size 19 valves reduced long-term survival, as did blood transfusion, highlighting the importance of strategies that reduce its requirement. We have shown that in patients aged over 68 years, relative survival was comparable to age-and gender-matched controls. Other investigators have emphasized the importance of additional clinical features including severe valve calcification, 23 a jet velocity of >4m/s, 24 and of a positive stress test 25 in helping the surgeon reach a decision regarding surgery. All patients in our study had symptomatic aortic valve disease. Previous series that also included asymptomatic patients with severe AS demonstrated a lower operative mortality and a long-term survival similar to that in symptomatic patients and comparable to an age-and gender-matched control population. 26 This data is important when making a decision regarding AVR, especially in the absence of symptoms. Our results and those of other groups would favor a policy of considering all patients with severe AS for surgery, irrespective of symptoms. 
Limitations
Since variables included in this retrospective study where those that were collected after 1995, other, possibly relevant, confounding factors may have been omitted. Our cardiac unit is the only one serving the local population and protocols and methods may be at variance with other foreign units, limiting its value with regard to generalizations. This study analysed overall survival and non-cardiac causes of mortality may have obscured the results, especially in older cohorts. Nevertheless the model of relative survival is designed to take this factor into account and to yield valuable data predicting life expectancy. A possible limitation from reliance on foreign life tables in the absence of reliable local data pertaining to differences in mortality in the very elderly was mitigated by goodness of fit analysis.
Conclusions
Certain risk predictors affect absolute long-term survival after AVR. Although absolute survival is shorter in older patients, increasing age had an incrementally smaller negative impact on relative survival such that patients over 68 years enjoyed a normal life expectancy after surgery. These findings provide important additional data when weighing up the risks and benefits of surgery for AVD.
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